Journals / Dicle Tıp Dergisi / 2020 / Cilt: 47 - Sayı: 3

Parkinson's Disease Profile – A 17-Year Patient Analysis

Pages
508–516
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Taking these results into consideration, we had the opportunity to correct our shortcomings in our future studies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:causes disability in advanced stages.
📊
Key Findings & Data:Factors that increase the risk in Parkinson's disease are male gender, old age, white race, environmental conditions, trauma, vascular diseases, family history, and genetic mutations.
💡
Conclusion & Impact:Taking these results into consideration, we had the opportunity to correct our shortcomings in our future studies.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

causes disability in advanced stages. The main pathology is the degeneration of the basal ganglia, especially the substantia nigra. In the clinic, motor and non-motor findings (NMF) are seen, and treatment approach is symptomatic. Factors that increase the risk in Parkinson's disease are male gender, old age, white race, environmental conditions, trauma, vascular diseases, family history, and genetic mutations. In this study, idiopathic Parkinson's patients who came to our movement disorders outpatient clinic in the last 17 years were evaluated retrospectively. We aimed to determine the IPD profile in our region through demographic and clinical findings and treatments used and compare the results with the literature. Methods: We evaluated 1150 patients admitted to the neurology department of movement disorders outpatient clinic due to parkinsonism. Five hundred seventy-eight patients with IPD were included in the study. Demographic data such as age, sex, place of birth, place of residence (rural/urban), comorbidities, family history, and habits were recorded. Results: A total of 63.5% of the patients were male. The mean age of the patients was 68.51(SD ± 10.35) years old for males and 68.37(SD ± 11.22) years old for females, 62.61(SD ± 11.31) for males and 62.55(SD ± 12.46) for females. 66.4% of the patients had the first clinical finding as tremor, while 55.4% had the tremor as the leading complaint. It was seen that 57% of the patients had NMF. It was observed that 52.8% of the patients did not have dementia. As the clinical stage progressed, it was determined that there was a significant increase in dementia rate. Hypertension (HT) (M/F%:35,2/47,2 p=0.01) and thyroid diseases (M/F%:2.3/10.3 p=0,00) were more frequent in female patients than in male patients. Impulsive-compulsive behaviors (ICBs) which are treatment-related problems were more common in males than in females (M/F%:17.8/8.5 p=0,00). Conclusion: The results were found to be similar to the literature. In this study, we have noticed the neglected, incomplete, or inadequately questioned parameters in routine-intensive outpatient conditions. Taking these results into consideration, we had the opportunity to correct our shortcomings in our future studies.

🔖

Cite This Article

ADIGUZEL, A., OZTURK, U., ALTINAYAR, S. (2022). Parkinson's Disease Profile – A 17-Year Patient Analysis. Dicle Tıp Dergisi, Cilt: 47 - Sayı: 3, 508–516. https://ajindex.com/articles/487356

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bekris LM, Mata IF, Zabetian CP. The Genetics of Parkinson Disease, Journal of Geriatric Psychiatry and Neurology. 2010; 23: 228–42
  2. Arikanoglu A, Hunkar R, Cınar K. Parkinsonism secondary to bilateral subdural hematoma. Dicle Med J. 2011; 38: 247-9
  3. Kalia LV, Lang AE. Parkinson disease in 2015: Evolving basic, pathological and clinical concepts in PD. Nat Rev Neurol. 2016; 12: 65–6
  4. Gaare JJ, Skeie GO, Tzoulis C, Larsen JP, Tysnes OB. Familial aggregation of Parkinson's disease may affect progression of motor symptoms and dementia. Movement disorders: official Journal of the Movement Disorder Society. 2017; 32: 241-45
  5. Breckenridge CB, Berry C, Chang ET, Sielken Jr RL, Mandel JS. Association between Parkinson’s Disease and Cigarette Smoking, Rural Living, Well-Water Consumption, Farming and Pesticide Use: Systematic Review and Meta-Analysis. PloS one. 2016; 11: e0151841
  6. Ritz B, Lee PC, Lassen CF, Arah OA. Parkinson disease and smoking revisited: ease of quitting is an early sign of the disease. Neurology. 2014; 83: 1396–402
  7. PD MED Collaborative Group. Long-term eff ectiveness of dopamine agonists and monoamine oxidase B inhibitors compared with levodopa as initial treatment for Parkinson’s disease (PD MED): a large, open-label, pragmatic randomised trial. Lancet. 2014; 384: 1196– 205
  8. Martin I, Dawson VL, Dawson TM. Recent advances in the genetics of Parkinson's disease. Annu Rev Genomics Hum Genet. 2011; 12: 301–25
  9. Driver JA, Logroscino G, Gaziano JM, Kurth T. Incidence and remaining lifetime risk of Parkinson disease in advanced age. Neurology. 2009; 72: 432–8
  10. Pringsheim T, Jette N, Frolkis A, Steeves TDL. The prevalence of Parkinson’s disease: a systematic review and meta-analysis. Mov Disord. 2014; 29: 1583–90
  11. Benito-León J1, Bermejo-Pareja F, Rodríguez J, et al. Prevalence of PD and other types of parkinsonism in three elderly populations of central Spain Neurological Disorders in Central Spain (NEDICES) Study Group. Mov disord. 2003; 18: 267-74
  12. Picillo M, Nicoletti A, Fetoni V, et al. The relevance of gender in Parkinson's disease: a review. J Neurol. 2017 Aug; 264(8): 1583-1607. doi: 10.1007/s00415-016- 8384-9. Epub 2017 Jan 4
  13. Noyce AJ, Bestwick JP, Silveira-Moriyama L, et al. Meta-analysis of early nonmotor features and risk factors for Parkinson disease. Ann Neurol. 2012; 72: 893–901
  14. Belvisi D, Conte A, Bologna M, et al. Re-emergent tremor in Parkinson's disease, Parkinsonism Relat Disord. 20